A controlled comparison of 5-fluoro-2'-deoxyuridine therapy administered by rapid intravenous injection and by continuous intravenous infusion.
D002986:Clinical Trials as Topic; D003967:Diarrhea / Q000139:chemically induced; D003875:Drug Eruptions; D005467:Floxuridine / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced; D007263:Infusions, Parenteral; D007275:Injections, Intravenous; D007414:Intestinal Neoplasms / Q000188:drug therapy*; D007420:Intestine, Large; D007970:Leukopenia / Q000139:chemically induced; D009325:Nausea / Q000139:chemically induced; D013223:Statistics as Topic; D013280:Stomatitis / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D005467:Floxuridine